US Stock MarketDetailed Quotes
TFFP TFF Pharmaceuticals
- 2.1162
- +0.0262+1.25%
Trading May 9 11:51 ET
8.86MMarket Cap-178P/E (TTM)
2.2100High2.0900Low5.36KVolume2.1000Open2.0900Pre Close11.45KTurnover0.14%Turnover RatioLossP/E (Static)4.18MShares17.500052wk High0.93P/B8.25MFloat Cap1.960052wk Low--Dividend TTM3.90MShs Float528.5000Historical High--Div YieldTTM5.74%Amplitude1.9600Historical Low2.1360Avg Price1Lot Size
TFF Pharmaceuticals Stock Forum
Sign in to post a comment
$TFF Pharmaceuticals(TFFP.US$ Just off ATL @2.51! OS on the daily! RSI 7 = 24.10 RSI 14 = 28.22! MACD Curling up, fixing to make that GC, if completes the trend? NFA Just thinking outloud!
2
16
$TFF Pharmaceuticals(TFFP.US$ TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering![]()
$TFF Pharmaceuticals(TFFP.US$
NEWS
TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering
NEWS
TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering
$TFF Pharmaceuticals(TFFP.US$ TFF Pharmaceuticals Announces Additional Positive Data From the Tacrolimus Inhalation Powder (TFF Tac) Phase 2 Trial Following Oral Presentation at the Ishlt 44TH Annual Late Breaking Clinical Science Abstract Sessions. TFF Pharmaceuticals Inc: Successful Transition of Eight of Eight Patients From Oral Tacrolimus to TFF Tac
1
$Annovis Bio(ANVS.US$ 22% Ph2/3 data reporting update
$Taysha Gene Therapies(TSHA.US$ 21% FY 2023 results
$TFF Pharmaceuticals(TFFP.US$ 14% Clinical programs update
$Jaguar Health(JAGX.US$ 14% Crofelemer commercialization
$Acelyrin(SLRN.US$ 4% Ph1/2 positive data
$Delcath Systems(DCTH.US$ 3% Closes $7M private placement
$Sellas Life Sciences(SLS.US$ 0% Closes $20M offering & private placement
$Immunic(IMUX.US$ 1% Patent notice of allowance
$Nurix Therapeutics(NRIX.US$ 0...
$Taysha Gene Therapies(TSHA.US$ 21% FY 2023 results
$TFF Pharmaceuticals(TFFP.US$ 14% Clinical programs update
$Jaguar Health(JAGX.US$ 14% Crofelemer commercialization
$Acelyrin(SLRN.US$ 4% Ph1/2 positive data
$Delcath Systems(DCTH.US$ 3% Closes $7M private placement
$Sellas Life Sciences(SLS.US$ 0% Closes $20M offering & private placement
$Immunic(IMUX.US$ 1% Patent notice of allowance
$Nurix Therapeutics(NRIX.US$ 0...
10
1
$Pfizer(PFE.US$ Phase 2
$Leap Therapeutics(LPTX.US$ Phase 2
$Vera Therapeutics(VERA.US$ Phase 2b
$4D Molecular Therapeutics(FDMT.US$ Phase 2
$Adverum Biotechnologies(ADVM.US$ Phase 2
$Denali Therapeutics(DNLI.US$ Phase 2
$Akero Therapeutics(AKRO.US$ Phase 2b
$Spruce Biosciences(SPRB.US$ Phase 2
$Xencor(XNCR.US$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US$ Phase 2
$Harmony Biosciences(HRMY.US$ Phase 2
$Annexon(ANNX.US$ Phase 2a
$Roivant Sciences(ROIV.US$...
$Leap Therapeutics(LPTX.US$ Phase 2
$Vera Therapeutics(VERA.US$ Phase 2b
$4D Molecular Therapeutics(FDMT.US$ Phase 2
$Adverum Biotechnologies(ADVM.US$ Phase 2
$Denali Therapeutics(DNLI.US$ Phase 2
$Akero Therapeutics(AKRO.US$ Phase 2b
$Spruce Biosciences(SPRB.US$ Phase 2
$Xencor(XNCR.US$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US$ Phase 2
$Harmony Biosciences(HRMY.US$ Phase 2
$Annexon(ANNX.US$ Phase 2a
$Roivant Sciences(ROIV.US$...
23
$Cellectar BioSciences(CLRB.US$ Phase 2
$Regenxbio(RGNX.US$ Phase 2
$Leap Therapeutics(LPTX.US$ Phase 2
$4D Molecular Therapeutics(FDMT.US$ Phase 2
$Adverum Biotechnologies(ADVM.US$ Phase 2
$Denali Therapeutics(DNLI.US$ Phase 2
$EyePoint Pharmaceuticals(EYPT.US$ Phase 2
$Xencor(XNCR.US$ Phase 2
$Harmony Biosciences(HRMY.US$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US$ Phase 2
$Disc Medicine(IRON.US$ Phase 2
$Atea Pharmaceuticals(AVIR.US$ Phase 2
$Allakos(ALLK.US$ Phase 2...
$Regenxbio(RGNX.US$ Phase 2
$Leap Therapeutics(LPTX.US$ Phase 2
$4D Molecular Therapeutics(FDMT.US$ Phase 2
$Adverum Biotechnologies(ADVM.US$ Phase 2
$Denali Therapeutics(DNLI.US$ Phase 2
$EyePoint Pharmaceuticals(EYPT.US$ Phase 2
$Xencor(XNCR.US$ Phase 2
$Harmony Biosciences(HRMY.US$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US$ Phase 2
$Disc Medicine(IRON.US$ Phase 2
$Atea Pharmaceuticals(AVIR.US$ Phase 2
$Allakos(ALLK.US$ Phase 2...
36
6
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
102494559 : 还会继续跌破吗
TrytosaveabitOP 102494559: It could continue down! I’m looking at this for a swing trade and I started buying at 2.01? That way if it drops more? Well I can just scale in a bit more! Most all my swing trades I scale in a bit at a time for that reason! IMO the chart is telling me it could go either way right now? NFA GL
102494559 : 不懂开始回涨没有
还是会跌破2.0
TrytosaveabitOP 102494559: Like I said it could go either way! One caveat! I am looking for company to release so kind of good PR soon?
102494559 TrytosaveabitOP: 我是新手学习和寻找意见中
View more comments...